-
Cangene Corp. (TSX:CNJ), Winnipeg, Manitoba Inspiration Biopharmaceuticals Inc., Cambridge, Mass. Ipsen Group (Euronext:IPN; Pink:IPSEY), Boulogne-Billancourt, France Business: Hematology Cangene acquired Inspiration's …
Published on 2/25/2013
-
Cepheid Inc. (NASDAQ:CPHD), Sunnyvale, Calif. Oregon Health & Science University, Portland, Ore. Business: Diagnostic Cepheid partnered with the university's Knight Cancer Institute to develop molecular cancer …
Published on 2/25/2013
-
Champions Oncology Inc. (OTCBB:CSBR), Baltimore, Md. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Cancer Champions (formerly Champions Biotechnology Inc.) received a one-time $880,000 …
Published on 2/25/2013
-
Chiesi Farmaceutici S.p.A., Parma, Italy Cornerstone Therapeutics Inc. (NASDAQ:CRTX), Cary, N.C. Business: Pulmonary Cornerstone said its board received a proposal from partner Chiesi to take Cornerstone private. Chiesi…
Published on 2/25/2013
-
China Shenghuo Pharmaceutical Holdings Inc. (Pink:CKUN), Kunming, China Lan's Int'l Medicine Investment Co. Ltd., Kunming, China Business: Pharmaceuticals China Shenghuo said its board received from Lan's a proposal to …
Published on 2/25/2013
-
ConfometRx, Santa Clara, Calif. UCB Group (Euronext:UCB), Brussels, Belgium Business: Neurology UCB and structural biology company ConfometRx partnered to research GPCR modulation to discover new therapies for …
Published on 2/25/2013
-
Galectin Therapeutics Inc. (NASDAQ:GALT), Norcross, Ga. University of Georgia, Athens, Ga. Business: Cancer, Inflammation Galectin and the university's Complex Carbohydrate Research Center partnered to discover …
Published on 2/25/2013
-
Illumina Inc. (NASDAQ:ILMN), San Diego, Calif. Verinata Health Inc., Redwood City, Calif. Business: Diagnostic Illumina completed its acquisition of prenatal testing company Verinata for $350 million, plus up to $100 …
Published on 2/25/2013
-
Isis Pharmaceuticals Inc. (NASDAQ:ISIS), Carlsbad, Calif. KineMed Inc., Emeryville, Calif. CHDI Foundation Inc., New York, N.Y. Business: Neurology Isis will use biomarkers from KineMed and the not-for-profit foundation…
Published on 2/25/2013
-
Lotus Tissue Repair Inc., Cambridge, Mass. Shire plc (LSE:SHP; NASDAQ:SHPG), Dublin, Ireland Business: Dermatology Shire disclosed in its 2012 earnings that it completed the acquisition of Lotus Tissue Repair for an …
Published on 2/25/2013
-
NexGen Medical Systems Inc., Melbourne, Fla. Stem Cell Therapeutics Corp. (TSX-V:SSS), Calgary, Alberta Business: Drug delivery, Neurology Stem Cell Therapeutics and NexGen will form a JV called ReNeu Inc. (Calgary, …
Published on 2/25/2013
-
Novation Holdings Inc. (OTCQB:NOHO), Boca Raton, Fla. AVM Licensing Corp., location undisclosed Business: Infectious, Other Novation sold its controlling interest in its medical device development subsidiary SureScreen …
Published on 2/25/2013
-
Pantarhei Bioscience B.V., Zeist, the Netherlands Actavis Inc. (NYSE:ACT), Parsippany, N.J. Business: Genitourinary Pantarhei sold its 30% stake in the Estetra S.A. JV to partner Actavis' Uteron Pharma S.A. for an …
Published on 2/25/2013
-
Affymax Inc. (NASDAQ:AFFY), Palo Alto, Calif. Fresenius Medical Care AG & Co. KGaA (Xetra:FME; NYSE:FMS), Bad Homburg, Germany Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Hematology Fresenius' …
Published on 2/18/2013
-
Agilent Technologies Inc. (NYSE:A), Santa Clara, Calif. Pfizer Inc. (NYSE:PFE), New York, N.Y. Business: Pharmacogenetics Agilent's Dako A/S company and Pfizer partnered for "various collaboration projects" in the field…
Published on 2/18/2013
-
Albany Molecular Research Inc. (NASDAQ:AMRI), Albany, N.Y. Bessor Pharma LLC, Framingham, Mass. Business: Cancer Translational drug development company Bessor exercised a 2012 option from contract research and …
Published on 2/18/2013
-
AntaBio, Labege, France Galapagos N.V. (Euronext:GLPG; Pink:GLPYY), Mechelen, Belgium Business: Infectious Galapagos' Argenta Discovery Ltd. service division will provide medicinal chemistry, computer-aided drug design …
Published on 2/18/2013
-
Biocon Ltd. (NSE:BIOCON; BSE:BIOCON), Bangalore, India Mylan Inc. (NASDAQ:MYL), Canonsburg, Pa. Business: Endocrine/Metabolic, Biosimilars Mylan partnered with Biocon to develop and commercialize Biocon's biosimilar …
Published on 2/18/2013
-
Brickell Biotech Inc., Miami, Fla. Signum Dermatologix Inc., Monmouth Junction, N.J. Business: Dermatology Last December, Brickell terminated an April 2012 deal with Signum (formerly Argyle Therapeutics Inc.) granting …
Published on 2/18/2013
-
Cadila Pharmaceuticals Ltd., Ahmedabad, India Pergamum AB, Solna, Sweden Business: Infectious The companies partnered to develop and commercialize an undisclosed therapeutic peptide to treat infectious diseases. …
Published on 2/18/2013
-
Cellmid Ltd. (ASX:CDY), Sydney, Australia Fujikura Kasei Co. Ltd. (Tokyo:4620), Tokyo, Japan Business: Diagnostic Fujikura received an option to license use of Cellmid's midkine (MDK; MK) diagnostic antibodies on …
Published on 2/18/2013
-
Celsion Corp. (NASDAQ:CLSN), Lawrenceville, N.J. Zhejiang Hisun Pharmaceutical Co. Ltd. (Shanghai:600267), Taizhou City, China Business: Cancer, Drug delivery Celsion said that Zhejiang Hisun does not plan to exercise …
Published on 2/18/2013
-
Chiasma Inc., Jerusalem, Israel Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Endocrine/Metabolic, Cancer, Drug delivery Chiasma was to announce on Feb. …
Published on 2/18/2013
-
China Nuokang Bio-Pharmaceutical Inc., Shenyang, China Business: Hematology, Cardiovascular China Nuokang said it has gone private after shareholders approved a proposal to go private from CEO and Chairman Baizhong Xue …
Published on 2/18/2013
-
Cylex Inc., Columbia, Md. ViraCor-IBT Laboratories Inc., Lee's Summit, Mo. Business: Diagnostic ViraCor-IBT will purchase the assets of Cylex, which develops and commercializes in vitro diagnostics for transplant …
Published on 2/18/2013